AESTURA's US retail launch began with a cream and a place to try it. On 22 January 2025, Amorepacific announced an exclusive Sephora partnership covering more than 400 US locations and Sephora.com, with availability from February. Subsequent issuer reporting described cream-led momentum. A March 2026 release then placed ATOBARRIER365 Cream among Sephora's top five US moisturisers, according to Amorepacific.

Amorepacific followed the shelf launch with people and places through which Americans could encounter the brand: specialist retail, dermatologist and influencer activity, and a New York pop-up shared with its other skincare names. That sequence gives the US entry more substance than a door count. AESTURA's role was also distinct within the portfolio: sensitive-skin care organised around ATOBARRIER365 Cream. The lead product gave an unfamiliar name a clear introduction, while the parent and Sephora supplied the commercial setting in which it could be discovered and bought again.

The announced USD 21-34 assortment and a mini kit made trial part of the retail proposition. The range was organised around an everyday skincare routine, with small formats for an initial introduction. Amorepacific supported that retail presence with dermatologist and influencer events. The proposition was accessible within a specialist beauty shop: start with a cream or a trial kit, then find complementary products in the same range.

One Cream Gives a New Shopper a Starting Point

Sephora skincare merchandising executive Brooke Banwart presented AESTURA as an addition to the retailer's Korean skincare assortment for clients seeking sensitive-skin products. AESTURA general manager Brian Lee described the move as bringing an established Korean proposition to a new audience. The named line included the cream and supporting cleansing, essence, serum, lotion and mist products. The exclusive Mini Best Sellers Kit contained trial sizes of cleanser, serum and cream, giving the launch a smaller first purchase as well as a full-size range.

That assortment explains the choice of a specialist retailer. ATOBARRIER365 offered a specific starting point within a much larger skincare selection, with complementary products for a routine. AESTURA and Sephora presented its dermatological background as the basis of its sensitive-skin positioning. Commercially, the cream carried much of the burden of making a new name memorable. A shopper could encounter one product, try its texture and return to the same retailer. The cleanser and serum gave that first choice an obvious next step within the same daily routine.

Amorepacific Takes Four Skincare Brands to Manhattan

On 24-25 October 2025, AESTURA appeared alongside LANEIGE, INNISFREE and HANYUL at Seoul in the City, Amorepacific's first US multi-brand skincare pop-up with Sephora. The company reported more than 3,500 visitors to the event at 45 West 25th Street, with a separate preview welcoming about 350 guests. Its New York setting made the launch strategy visible: the newer brand could appear beside names already familiar to the group's American customers. The four brands shared the setting and the audience.

Visitors moved through Seoul-inspired settings, including a derma-clinic concept, and could shop at a dedicated Sephora checkout while earning Beauty Insider points. Amorepacific North America chief Giovanni Valentini emphasised cultural storytelling and discovery; Sephora marketing executive Mili Dutt Reddy described the in-person educational purpose. The event also extended to selected New York Sephora stores and a Korea Tourism Organization raffle. The parent was putting AESTURA into a US customer event after securing its retail listing, with a checkout available during the experience.

The event began with a product wishlist. Visitors collected stamps at the brand booths and could redeem samples, merchandise and Korean snacks at the exit. A Charm Bar offered a personalised lip keychain as a gift with purchase. Those small activities made discovery social and tangible, placing an unfamiliar sensitive-skin brand within a broader Korean beauty experience. The accompanying samples also allowed visitors to take part of that introduction home.

Announced US retail locations400+

US Sephora distribution footprint announced on 22 January 2025 for the rollout beginning in February.

Source 1

The Cream Becomes Part of the Parent's American Growth

In the quarter before the Manhattan event, the cream was already gaining American customers, according to Amorepacific's subsequent operating account. The July-September presentation, released on 6 November, described strong ATOBARRIER365 sales momentum, dermatologist and skincare-influencer events, and a larger US offline presence. Corporation-wide Americas revenue reached KRW 156.8 billion, up 6.9%. AESTURA was one of several brands in a portfolio that included LANEIGE, INNISFREE, HANYUL and COSRX. Management also reported pressure on Western profitability from new-brand marketing and weaker COSRX sales. AESTURA was gaining a foothold while its parent was working through a more uneven regional expansion.

AESTURA Adds a Continental European Rollout

By 5 March 2026, Amorepacific was reporting the cream among Sephora's top five US moisturisers. The company did not give the ranking period. It also reported more than ten million cumulative cream sales globally, showing the established product behind the American introduction.

The company was already using the product to lead another expansion. After a February European online pre-launch, it described a sequential rollout to approximately 680 Sephora stores across seventeen countries, with AESTURA featured in the retailer's Skincare Trend Story campaign. Q3 reporting had separately recorded UK entry. The progression is distinctive: a Korean daily-use cream gained a US specialist-retail route, appeared in the parent's customer events and then led a wider European programme. The cream would be accompanied by its serum and Hydro Soothing Cream. AESTURA was extending the routine that had introduced it to American shoppers, with a focused product selection instead of asking a new market to absorb its entire catalogue.

DSML research · 8 October 2026 · Revised 31 October 2026